The SUNY team, led by John Hui, have treated 18
chest pain patients over the past two years for whom traditional treatment had failed to work or who were too ill to undergo surgery.
Patients who didn't seek follow - up care within a month received the lowest rate of care and had the worst health outcomes — demonstrating the need to improve follow - up with high risk
chest pain patients after they're discharged from the emergency room, Ko said.
Only 17 percent of high risk
chest pain patients seen in the emergency room were evaluated by cardiologists within a month; 58 percent saw a primary care physicians alone, and 25 percent had no physician follow - up within a month.
«We'd like to see more emergency medicine physicians having that bedside conversation to ensure
the chest pain patient knows the risks and benefits of hospitalization compared to outpatient evaluation.
Not exact matches
The number of
patients treated with nitroglycerin, a drug used for
chest pain and heart failure, increased by 89 percent.
«Every call for medical assistance is important and ambulance dispatching is prioritized so life - threatening calls — for a choking child, cardiac arrest or
chest pains — take precedence over non-life-threatening injuries — where the
patient is breathing, alert and communicating,» the statement said.
In that experiment, researchers from a collective of Scandinavian countries, and funded by Merck, followed more than 4,400
patients who had
chest pain or had suffered a heart attack.
Researchers at Johns Hopkins Bayview Medical Center used two relatively simple tactics to significantly reduce the number of unnecessary blood tests to assess symptoms of heart attack and
chest pain and to achieve a large decrease in
patient charges.
In 2010, the researchers report, more than 17 million
patients with
chest pain visiting an emergency department in the United States received cardiac biomarker testing.
As time went by, «my fear,» he says, «was to be drunk and have a
patient call me and say, «I have
chest pain,» and have me tell him, «Okay, go play tennis.»»
Current guidelines strongly suggest that
patients discharged from emergency departments for
chest pain should be seen by a physician within 72 hours for further assessment or treatment.
Because the study focused on high risk
patients, the results may not apply to all who have
chest pain.
Chest pain is the most common reason
patients go to the ER.
The study looked at 56 767
patients with
chest pain who visited an emergency department in Ontario between April 2004 and March 2010.
Patients with multiple health issues and who are at higher risk of adverse events are less likely to receive follow - up care from a physician after visiting an emergency department for
chest pain, reports a study published in CMAJ (Canadian Medical Association Journal)
«One in four
patients who visited emergency department for
chest pain did not receive follow - up care.»
«Our study suggests that system factors such as access to care and emergency department annual
chest pain volume are the strongest predictors of follow - up rather than
patient factors.
The heart
patient doesn't succumb to
chest pain until her artery is 90 percent blocked.
Participating emergency department physicians — both staff physicians and residents — evaluating
patients with abdominal
pain,
chest pain / shortness of breath, or headache were asked to complete brief surveys after their initial evaluation of the
patients and again after receiving CT scan results.
«Aggressive testing provides no benefit to
patients in ER with
chest pain: CT scans, cardiac stress tests don't help in ruling out heart attack.»
Patients seen in the emergency department (ED) for
chest pain who did not have a heart attack appeared to be at low risk of experiencing a heart attack during short - and longer - term follow - up and that risk was not affected by the initial diagnostic testing strategy, according to a study published online by JAMA Internal Medicine.
In a pilot study involving 13
patients with non-cardiac
chest pain, Dr. Schey and his research team found that
patients who were given 5 mg of dronabinol twice daily for four weeks fared better than
patients who took a placebo, or dummy pill.
The
patients with
chest pain diagnoses were classified into 1 of 5 testing strategies: no noninvasive testing, exercise electrocardiography (EE, evaluates the heart's electrical activity), stress echocardiography (SE, ultrasound), myocardial perfusion scintigraphy (MPS, scan of heart) or coronary computed tomography angiography (CCTA, CT imaging).
«Our study suggests that in the emergency room, stress testing and CT scans are unnecessary for evaluating
chest pain in possible heart attack
patients,» said cardiologist and senior author David L. Brown, MD, a professor of medicine.
Nationwide, the overwhelming majority of
patients evaluated for
chest pain in the ER get such extra tests, Brown said.
It is time to change our guidelines and practice for treatment of
chest pain in low - risk
patients.
Patients who go to the emergency room (ER) with
chest pain often receive unnecessary tests to evaluate whether they are having a heart attack, a practice that provides no clinical benefit and adds hundreds of dollars in health - care costs, according to a new study from researchers at Washington University School of Medicine in St. Louis.
About 6 million
patients are seen in EDs annually for
chest pain or other symptoms suggestive of myocardial ischemia (decreased blood flow to the heart).
With 10 million
patients coming to the ER for
chest pain each year in the United States, these extra costs add up, according to the investigators.
«The goal of evaluating
patients with
chest pain in the ER is not to screen for coronary artery disease,» he said.
Only 10 to 20 percent of
patients who present to EDs with suspected cardiac - related
chest pain are diagnosed with acute MI.
An analysis of diagnostic test results from the Prospective Multicenter Imaging Study for Evaluation of
Chest Pain (PROMISE) trial — in which patients with stable chest pain were randomized to either anatomic or functional testing as an initial diagnostic strategy — showed that the presence and extent of coronary artery disease detected by CT angiography better predicted the risk for future cardiac events than did measures of exercise tolerance or restricted blood flow to the heart mu
Chest Pain (PROMISE) trial — in which
patients with stable
chest pain were randomized to either anatomic or functional testing as an initial diagnostic strategy — showed that the presence and extent of coronary artery disease detected by CT angiography better predicted the risk for future cardiac events than did measures of exercise tolerance or restricted blood flow to the heart mu
chest pain were randomized to either anatomic or functional testing as an initial diagnostic strategy — showed that the presence and extent of coronary artery disease detected by CT angiography better predicted the risk for future cardiac events than did measures of exercise tolerance or restricted blood flow to the heart muscle.
«While these observational data can not prove that treating
patients based on the results of CTA testing will automatically result in better health outcomes, they do provide new information enabling a more informed choice of testing for
patients with stable
chest pain, especially for predicting future cardiovascular risk.»
«CT angiography appears better at predicting future risk for
patients with
chest pain: Ability to reveal nonobstructive coronary artery disease identifies at - risk
patients missed by functional testing.»
The PROMISE trial was conducted at 193 centers across North America to determine whether a care strategy starting with coronary CTA, which reveals the structure of blood vessels supplying the heart, or a strategy starting with functional testing, measures such as stress testing or echocardiography that reflect how well the heart muscle is working, provided better guidance for clinical decisions regarding
patients with
chest pain.
Clinicians should be aware of this and also consider that
patients who arrive in the emergency department with signs of heart attacks, such as
chest pain and breathlessness, but after a happy event or emotion, could be suffering from TTS just as much as a similar
patient presenting after a negative emotional event.
Since this relatively rare condition was first described in 1990, evidence has suggested that it is typically triggered by episodes of severe emotional distress, such as grief, anger or fear, with
patients developing
chest pains and breathlessness.
Joachim Fandrey, a physiologist at the University of Duisburg - Essen in Germany, adds that the results suggest that nitroglycerin patches, which have a long track record in treating
chest pain in heart disease
patients, might boost EPO production in people suffering from anemia due to kidney disease or cancer.
«One
patient developed a facial rash, another flu - like symptoms and two had some
chest pain after the injection,» says Pasricha.
This study investigated the application of the troponin I assay for the diagnosis of AMI in 1,040
patients presenting to the emergency department with acute
chest pain.
The researchers drew
patients from a large trial focusing on the use of CCTA in people who had come to the emergency department with acute
chest pain.
«The strength of our study is that it provides a real world assessment of how testing in
patients with
chest pain has an impact on the subsequent health of
patients with
chest pain,» said lead author Pamela Douglas, M.D., Geller Professor of Research in Cardiovascular Diseases at the Duke Clinical Research Institute.
Patients with
chest pain have similar rates of heart attacks and other major cardiac events within two years whether they were evaluated with a new type of CT scan or the traditional stress test, according to results presented today by Duke Medicine researchers at a meeting of the American College of Cardiology.
«We were looking at the optimum way to evaluate people with
chest pain and focusing on those
patients who are generally older, have many risk factors for coronary disease or may have had prior health problems, basically the intermediate to higher risk population,» Miller said.
«Cardiac MRI use reduces adverse events for
patients with acute
chest pain.»
From 10 different hospitals throughout the country, researchers recruited
patients who were undergoing angioplasty for either a heart attack or
chest pain.
At the time of their procedure,
patients answered questionnaires about their
chest pain and overall quality of life, which were repeated at one, six, and 12 months later.
Patients diagnosed with depression were more likely to be women and report more severe
chest pain based on a validated angina scale.
The study included 22,917
patients from 19 medical centers in Ontario, Canada, who received a diagnosis of stable coronary artery disease following coronary angiogram for
chest pain (chronic stable angina) between Oct. 1, 2008, and Sept. 30, 2013.
Through the UCSD Clinical Cardiovascular Cell Therapy program, Dib and collaborating cardiology faculty plan to conduct clinical studies in a number of areas, including the effectiveness of adult stem cell transplant as a treatment for congestive heart failure; as a way to minimize heart damage after a heart attack; and in the formation of new blood vessels (angiogenesis) to increase blood flow to the heart for
patients experiencing
chest pain.